2010
DOI: 10.1016/j.rdc.2010.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Manifestations and Treatment of Churg-Strauss Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
75
1
15

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 91 publications
(96 citation statements)
references
References 61 publications
1
75
1
15
Order By: Relevance
“…[2][3][4] As seen in our patient, rheumatoid meningitis can develop irrespective of systemic inflammation and arthritis. [2,5] The rarity of diagnosis limits available information about the disease, with the largest case series using less than two dozen patients.…”
Section: Discussionsupporting
confidence: 68%
See 2 more Smart Citations
“…[2][3][4] As seen in our patient, rheumatoid meningitis can develop irrespective of systemic inflammation and arthritis. [2,5] The rarity of diagnosis limits available information about the disease, with the largest case series using less than two dozen patients.…”
Section: Discussionsupporting
confidence: 68%
“…[8] Brain imaging traditionally shows meningeal thickening and localized enhancement. [4] MRI is the preferred imaging modality, although contrast CT can be used for diagnosis, as seen in our patient who could not undergo MRI due to pacemaker placement. [2,9] CSF studies often show elevated protein, with potential CSF biomarkers of disease activity including IL-6 and RF.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…Two case reports have described success with methotrexate as maintenance therapy [105,107]. Various biologic therapies have also been used with good effect in isolated cases of refractory, systemic CSS, including etanercept, infliximab, rituximab, and omalizumab [93,111]. Although these cases did not specifically address orbital disease, the aforementioned biologics may also be useful in refractory orbital CSS.…”
Section: Churg-strauss Syndromementioning
confidence: 99%
“…[1,2] Specifically, organ damage secondary to eosinophil infiltration underlies airway and lung parenchymal, cardiac and gut involvement, while mononeuritis multiplex, glomerulonephritis and purpura characterize the vasculitic phase. [3][4][5] We report the clinical disease course of a gentleman with steroid-resistant EGPA characterized by recalcitrant peripheral eosinophilia, central and peripheral nervous system involvement, myocarditis, diffuse alveolar hemorrhage (DAH), necrotizing myopathy, and extensive eosinophilic degranulation in gastrointestinal tissues; the latter only apparent after staining with targeted monoclonal antibodies to eosinophil peroxidase (EPX). This case highlights the synchronous presentation of multiple rare manifestations of EGPA, highlighting the multisystem complexity and clinical heterogeneity of this disease entity.…”
Section: Introductionmentioning
confidence: 99%